KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $185.1 million.

  • Exact Sciences' Shares Outstanding (Weighted Average) rose 2.46% to $189.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.3 million, marking a year-over-year increase of 2.46%. This contributed to the annual value of $185.1 million for FY2024, which is 2.34% up from last year.
  • Latest data reveals that Exact Sciences reported Shares Outstanding (Weighted Average) of $185.1 million as of FY2024, which was up 2.34% from $180.8 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Shares Outstanding (Weighted Average) registered a high of $185.1 million during FY2024, and its lowest value of $150.4 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $180.8 million (2023), whereas its average is $181.2 million.
  • Data for Exact Sciences' Shares Outstanding (Weighted Average) shows a peak YoY increased of 15.86% (in 2020) over the last 5 years.
  • Exact Sciences' Shares Outstanding (Weighted Average) (Yearly) stood at $150.4 million in 2020, then increased by 14.56% to $172.3 million in 2021, then grew by 3.11% to $177.7 million in 2022, then increased by 1.78% to $180.8 million in 2023, then increased by 2.34% to $185.1 million in 2024.